文献速递衰弱、肌少症与跌倒老年综合评估

韩国版SARC-F肌少症筛查问卷的验证:韩国衰弱与老龄化队列研究

Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study.
PubMed 文献 · J Am Med Dir Assoc · 2017-08-31

基于韩国衰弱与老龄化队列研究1222名70岁及以上社区老年人,验证韩语版SARC-F肌少症筛查工具。SARC-F≥4组握力更差、步速更慢、躯体功能与认知功能更差、生活质量更低。该工具敏感性低但特异性高、阴性预测值高,适合临床快速排除肌少症。

要点

  • 韩语版SARC-F在社区老年人中特异性高、阴性预测值高,适合快速排除肌少症。
  • SARC-F≥4组握力、步速、躯体功能、认知功能及生活质量均较差。
  • SARC-F敏感性较低,阳性者仍需按欧洲、国际及亚洲标准进一步诊断。

核心结论

  • 韩语版SARC-F具有高特异性和高阴性预测值,可用于临床快速排除肌少症。
  • SARC-F诊断的肌少症与躯体功能、认知功能及生活质量相关。

研究设计与样本

  • 基于韩国衰弱与老龄化队列研究第一年基线数据,纳入1222名70岁及以上符合选择标准的社区老年人。
  • SARC-F以文化适应方式翻译为韩语,按总分分为SARC-F<4与SARC-F≥4两组,按性别分析其与步速、握力、日常活动能力及健康相关生活质量的相关性。

主要发现

  • SARC-F判定的肌少症患病率男性为4.2%,女性为15.3%。
  • 与欧洲、国际及亚洲肌少症诊断标准相比,SARC-F敏感性较低(男性11%-60%,女性28%-34%)。
  • SARC-F特异性高(男性96.6%-98%,女性85%-87.7%),阴性预测值高(男性89.2%-99.3%,女性88.5%-98.4%)。
  • SARC-F≥4组较SARC-F<4组握力更差、步速更慢、躯体功能更差、认知功能更差、生活质量更低(EuroQol-5 dimension评分更高)。

关键数值与推荐

  • SARC-F总分由5个项目(力量、行走协助、从椅子起身、爬楼梯、跌倒)得分相加,以4分为界分为SARC-F<4与SARC-F≥4两组。
  • 以欧洲、国际及亚洲肌少症工作组诊断标准为参照验证SARC-F。

临床怎么用

  • 可将韩语版SARC-F用于社区老年人肌少症的快速排除筛查,SARC-F<4者肌少症可能性低。
  • SARC-F≥4者应进一步评估握力、步速、躯体功能、认知功能及生活质量,并按标准诊断流程确认肌少症。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The SARC-F is a simple sarcopenia screening tool comprising 5 assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls. The present study aimed to examine the validation of the Korean version of SARC-F for elderly individuals residing in communities. SETTING AND PARTICIPANTS: From the first year baseline data of Korean Frailty and Aging Cohort Study, a total of 1222 elderly individuals (70 years and older) who met the study's selection criteria were included in the analysis. MEASUREMENTS: The SARC-F was translated into the Korean language in a culturally responsive way. The total score was calculated by adding the scores on the 5 items. The participants were divided into 2 groups according to the total score (SARC-F <4 vs SARC-F ≥4), and its correlations with various factors including walking speed, hand grip, ability to perform everyday activities, and health-related quality of life, were examined by sex. In addition, the tool's validity was analyzed by comparing it with the European, international, and Asian sarcopenia working group diagnostic criteria for sarcopenia. RESULTS: The prevalence of sarcopenia according to the SARC-F was 4.2% in among men and 15.3% in women. The sensitivity of the SARC-F was low compared with the European, international, and Asian criteria of sarcopenia [male (M): 11%-60%, female (F): 28%-34%]. However, SARC-F showed a high specificity (M: 96.6%-98%, F: 85%-87.7%) and a high negative predictive value (M: 89.2%-99.3%, F: 88.5%-98.4%). The participants in the SARC-F ≥4 group had poorer grip strength, slower walking speed, poorer physical performance, poorer cognitive function, and a lower quality of life (a high EuroQol-5 dimension score) than the participants in the SARC-F <4 group. CONCLUSIONS: The Korean language version of SARC-F showed a high specificity and high negative predictive value. As such, the tool is useful for briefly ruling out sarcopenia in a clinical setting. In addition, diagnosis of sarcopenia using the SARC-F was found to be associated with physical performance, cognitive function, and the quality of life.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Kim S, Kim M, Won CW, et al. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc. 2017. PMID: 28843526. doi:10.1016/j.jamda.2017.07.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。